[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fvsd8JZX5UD6L4kBBAv9PQ-f_roBbk9mcTpfgfZq-dew":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":83,"rows":90},"National and Kapodistrian University of Athens",[4],157,false,42,8,29831,20,123,[14,17,20,22,25,27,29,31],{"name":15,"count":16},"Infertility",5,{"name":18,"count":19},"Dental Plaque",4,{"name":21,"count":19},"Aortic Valve Stenosis",{"name":23,"count":24},"Knee Osteoarthritis",3,{"name":26,"count":24},"Postoperative Pain",{"name":28,"count":24},"Hip Fractures",{"name":30,"count":24},"Atrial Fibrillation",{"name":32,"count":24},"Breast Cancer",[34,39,44,49,54,59,64,68,73,78],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT06949176","Clinical Investigation of Chemomechanical Parameters for an Efficient Disinfection of the Root Canal","2024-12-12","Sodium Hypochlorite.",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT06822608","Evaluation of Dexpanthenol and Hyaluronic Acid Eye Drops on Corneal Epithelialization After Trans Epithelial PRK","2025-11","dexpanthenol and hyaluronic acid preservative-free eye artificial tears eye drops",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT07304479","Effects of Sevoflurane Versus Desflurane Anesthesia Under Protective Mechanical Ventilation for Robotic Assisted Surgery","2026-01-30","Sevoflurane",{"nctId":50,"briefTitle":51,"date":52,"intervention":53},"NCT06655506","Enhanced Recovery Protocols in Gynecologic Oncology","2026-03-31","ERAS group",{"nctId":55,"briefTitle":56,"date":57,"intervention":58},"NCT06069310","Mepolizumab Effectiveness in Patients With Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe Eosinophilic Asthma","2026-08-31","Mepolizumab 100 MG",{"nctId":60,"briefTitle":61,"date":62,"intervention":63},"NCT07245121","Perineural Prolotherapy in Chronic Knee Osteoarthritis Pain.","2026-12","Dextrose 5% and Lidocaine",{"nctId":65,"briefTitle":66,"date":62,"intervention":67},"NCT07296653","Prolotherapy in Acupoints in Chronic Non-specific Low Back Pain (cLBP)","Dextrose 15% and lidocaine 1% infiltration",{"nctId":69,"briefTitle":70,"date":71,"intervention":72},"NCT07589478","Augmentation of Arthroscopic Rotator Cuff Repair With Reimplantation of Subacromial Bursa Tissue and Platelet-Rich Plasma","2027-01","Subacromial Bursa Tissue Reimplantation",{"nctId":74,"briefTitle":75,"date":76,"intervention":77},"NCT07077122","Evaluation of the Systemic Burden of Non-surgical Periodontal Therapy: A Randomized Clinical Trial on Five Different Treatment Protocols","2027-07-15","antibiotic prophylaxis",{"nctId":79,"briefTitle":80,"date":81,"intervention":82},"NCT07408193","The Role of Coadministration of Lidocaine and Ketamine in Opioid-Refractory Chronic Cancer-Related Pain.","2027-08","Lidocaine and Ketamine",[84,85,86,87,88,89],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[91,119,142,166,188,206,229,247,273,291,309,333,351,374,392,419,437,463,481,505,527,555,573,598,625,643,670,694,712,738,764,789,807,834,852,878,896,921,939,966,995,1013,1037,1061,1089,1107,1133,1151,1176,1194,1212,1236,1263,1281,1299,1328,1346,1364],{"intervention":92,"totalTrials":93,"cells":94},"Beta blocker",1,{"EARLY_PHASE1":95,"PHASE1":98,"PHASE2":100,"PHASE3":102,"PHASE4":104,"NA":117},{"trials":96,"activeCount":97},[],0,{"trials":99,"activeCount":97},[],{"trials":101,"activeCount":97},[],{"trials":103,"activeCount":97},[],{"trials":105,"activeCount":93,"soonestReadout":111},[106],{"nctId":107,"briefTitle":108,"status":109,"phases":110,"primaryCompletion":111,"completion":112,"start":113,"enrollment":114,"conditions":115,"interventions":116},"NCT05721170","Impact of Beta Blockers on TAVI (BETA-TAVI)","RECRUITING",[88],"2028-01-30","2028-01-31","2024-06-01",347,[21],[92],{"trials":118,"activeCount":97},[],{"intervention":43,"totalTrials":93,"cells":120},{"EARLY_PHASE1":121,"PHASE1":123,"PHASE2":125,"PHASE3":127,"PHASE4":129,"NA":140},{"trials":122,"activeCount":97},[],{"trials":124,"activeCount":97},[],{"trials":126,"activeCount":97},[],{"trials":128,"activeCount":97},[],{"trials":130,"activeCount":93,"soonestReadout":42},[131],{"nctId":40,"briefTitle":41,"status":132,"phases":133,"primaryCompletion":42,"completion":134,"start":135,"enrollment":136,"conditions":137,"interventions":139},"NOT_YET_RECRUITING",[88],"2026-01","2025-02",68,[138],"Corneal Epithelial Wound Healing",[43],{"trials":141,"activeCount":97},[],{"intervention":143,"totalTrials":93,"cells":144},"Anifrolumab",{"EARLY_PHASE1":145,"PHASE1":147,"PHASE2":149,"PHASE3":160,"PHASE4":162,"NA":164},{"trials":146,"activeCount":97},[],{"trials":148,"activeCount":97},[],{"trials":150,"activeCount":93,"soonestReadout":155},[151],{"nctId":152,"briefTitle":153,"status":109,"phases":154,"primaryCompletion":155,"completion":155,"start":156,"enrollment":11,"conditions":157,"interventions":159},"NCT07584083","Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial)",[86],"2028-06","2026-04-29",[158],"Antiphospholipid Syndrome (APS)",[143],{"trials":161,"activeCount":97},[],{"trials":163,"activeCount":97},[],{"trials":165,"activeCount":97},[],{"intervention":82,"totalTrials":93,"cells":167},{"EARLY_PHASE1":168,"PHASE1":178,"PHASE2":180,"PHASE3":182,"PHASE4":184,"NA":186},{"trials":169,"activeCount":93,"soonestReadout":81},[170],{"nctId":79,"briefTitle":80,"status":132,"phases":171,"primaryCompletion":81,"completion":81,"start":172,"enrollment":173,"conditions":174,"interventions":176},[84],"2026-03",24,[175],"Opioid-Refractory Chronic Cancer-Related Pain",[82,177],"Active Placebo (Midazolam)",{"trials":179,"activeCount":97},[],{"trials":181,"activeCount":97},[],{"trials":183,"activeCount":97},[],{"trials":185,"activeCount":97},[],{"trials":187,"activeCount":97},[],{"intervention":177,"totalTrials":93,"cells":189},{"EARLY_PHASE1":190,"PHASE1":196,"PHASE2":198,"PHASE3":200,"PHASE4":202,"NA":204},{"trials":191,"activeCount":93,"soonestReadout":81},[192],{"nctId":79,"briefTitle":80,"status":132,"phases":193,"primaryCompletion":81,"completion":81,"start":172,"enrollment":173,"conditions":194,"interventions":195},[84],[175],[82,177],{"trials":197,"activeCount":97},[],{"trials":199,"activeCount":97},[],{"trials":201,"activeCount":97},[],{"trials":203,"activeCount":97},[],{"trials":205,"activeCount":97},[],{"intervention":67,"totalTrials":93,"cells":207},{"EARLY_PHASE1":208,"PHASE1":219,"PHASE2":221,"PHASE3":223,"PHASE4":225,"NA":227},{"trials":209,"activeCount":93,"soonestReadout":62},[210],{"nctId":65,"briefTitle":66,"status":109,"phases":211,"primaryCompletion":62,"completion":212,"start":213,"enrollment":214,"conditions":215,"interventions":217},[84],"2027-02","2025-12-01",60,[216],"Chronic Non-specific Low Back Pain",[67,218],"Lidocaine 1% infiltration",{"trials":220,"activeCount":97},[],{"trials":222,"activeCount":97},[],{"trials":224,"activeCount":97},[],{"trials":226,"activeCount":97},[],{"trials":228,"activeCount":97},[],{"intervention":218,"totalTrials":93,"cells":230},{"EARLY_PHASE1":231,"PHASE1":237,"PHASE2":239,"PHASE3":241,"PHASE4":243,"NA":245},{"trials":232,"activeCount":93,"soonestReadout":62},[233],{"nctId":65,"briefTitle":66,"status":109,"phases":234,"primaryCompletion":62,"completion":212,"start":213,"enrollment":214,"conditions":235,"interventions":236},[84],[216],[67,218],{"trials":238,"activeCount":97},[],{"trials":240,"activeCount":97},[],{"trials":242,"activeCount":97},[],{"trials":244,"activeCount":97},[],{"trials":246,"activeCount":97},[],{"intervention":38,"totalTrials":93,"cells":248},{"EARLY_PHASE1":249,"PHASE1":251,"PHASE2":253,"PHASE3":255,"PHASE4":257,"NA":259},{"trials":250,"activeCount":97},[],{"trials":252,"activeCount":97},[],{"trials":254,"activeCount":97},[],{"trials":256,"activeCount":97},[],{"trials":258,"activeCount":97},[],{"trials":260,"activeCount":93,"soonestReadout":37},[261],{"nctId":35,"briefTitle":36,"status":262,"phases":263,"primaryCompletion":37,"completion":264,"start":265,"enrollment":266,"conditions":267,"interventions":270},"ACTIVE_NOT_RECRUITING",[89],"2025-06-23","2023-12-01",44,[268,269],"Apical Periodontitis","Root Canal Infection",[38,271,272],"Hydrogen peroxide.","Sodium Sulfate.",{"intervention":271,"totalTrials":93,"cells":274},{"EARLY_PHASE1":275,"PHASE1":277,"PHASE2":279,"PHASE3":281,"PHASE4":283,"NA":285},{"trials":276,"activeCount":97},[],{"trials":278,"activeCount":97},[],{"trials":280,"activeCount":97},[],{"trials":282,"activeCount":97},[],{"trials":284,"activeCount":97},[],{"trials":286,"activeCount":93,"soonestReadout":37},[287],{"nctId":35,"briefTitle":36,"status":262,"phases":288,"primaryCompletion":37,"completion":264,"start":265,"enrollment":266,"conditions":289,"interventions":290},[89],[268,269],[38,271,272],{"intervention":272,"totalTrials":93,"cells":292},{"EARLY_PHASE1":293,"PHASE1":295,"PHASE2":297,"PHASE3":299,"PHASE4":301,"NA":303},{"trials":294,"activeCount":97},[],{"trials":296,"activeCount":97},[],{"trials":298,"activeCount":97},[],{"trials":300,"activeCount":97},[],{"trials":302,"activeCount":97},[],{"trials":304,"activeCount":93,"soonestReadout":37},[305],{"nctId":35,"briefTitle":36,"status":262,"phases":306,"primaryCompletion":37,"completion":264,"start":265,"enrollment":266,"conditions":307,"interventions":308},[89],[268,269],[38,271,272],{"intervention":48,"totalTrials":93,"cells":310},{"EARLY_PHASE1":311,"PHASE1":313,"PHASE2":315,"PHASE3":317,"PHASE4":319,"NA":321},{"trials":312,"activeCount":97},[],{"trials":314,"activeCount":97},[],{"trials":316,"activeCount":97},[],{"trials":318,"activeCount":97},[],{"trials":320,"activeCount":97},[],{"trials":322,"activeCount":93,"soonestReadout":47},[323],{"nctId":45,"briefTitle":46,"status":109,"phases":324,"primaryCompletion":47,"completion":325,"start":326,"enrollment":327,"conditions":328,"interventions":331},[89],"2026-02-28","2025-05-01",50,[329,330],"Respiratory Mechanics","Intraoperative",[48,332],"Desflurane",{"intervention":332,"totalTrials":93,"cells":334},{"EARLY_PHASE1":335,"PHASE1":337,"PHASE2":339,"PHASE3":341,"PHASE4":343,"NA":345},{"trials":336,"activeCount":97},[],{"trials":338,"activeCount":97},[],{"trials":340,"activeCount":97},[],{"trials":342,"activeCount":97},[],{"trials":344,"activeCount":97},[],{"trials":346,"activeCount":93,"soonestReadout":47},[347],{"nctId":45,"briefTitle":46,"status":109,"phases":348,"primaryCompletion":47,"completion":325,"start":326,"enrollment":327,"conditions":349,"interventions":350},[89],[329,330],[48,332],{"intervention":63,"totalTrials":93,"cells":352},{"EARLY_PHASE1":353,"PHASE1":355,"PHASE2":357,"PHASE3":359,"PHASE4":361,"NA":363},{"trials":354,"activeCount":97},[],{"trials":356,"activeCount":97},[],{"trials":358,"activeCount":97},[],{"trials":360,"activeCount":97},[],{"trials":362,"activeCount":97},[],{"trials":364,"activeCount":93,"soonestReadout":62},[365],{"nctId":60,"briefTitle":61,"status":109,"phases":366,"primaryCompletion":62,"completion":212,"start":367,"enrollment":214,"conditions":368,"interventions":372},[89],"2025-11-24",[369,370,371,23],"Chronic Pain","Perineural Analgesia","Prolotherapy",[63,373],"Lidocaine",{"intervention":373,"totalTrials":93,"cells":375},{"EARLY_PHASE1":376,"PHASE1":378,"PHASE2":380,"PHASE3":382,"PHASE4":384,"NA":386},{"trials":377,"activeCount":97},[],{"trials":379,"activeCount":97},[],{"trials":381,"activeCount":97},[],{"trials":383,"activeCount":97},[],{"trials":385,"activeCount":97},[],{"trials":387,"activeCount":93,"soonestReadout":62},[388],{"nctId":60,"briefTitle":61,"status":109,"phases":389,"primaryCompletion":62,"completion":212,"start":367,"enrollment":214,"conditions":390,"interventions":391},[89],[369,370,371,23],[63,373],{"intervention":53,"totalTrials":93,"cells":393},{"EARLY_PHASE1":394,"PHASE1":396,"PHASE2":398,"PHASE3":400,"PHASE4":402,"NA":404},{"trials":395,"activeCount":97},[],{"trials":397,"activeCount":97},[],{"trials":399,"activeCount":97},[],{"trials":401,"activeCount":97},[],{"trials":403,"activeCount":97},[],{"trials":405,"activeCount":93,"soonestReadout":52},[406],{"nctId":50,"briefTitle":51,"status":109,"phases":407,"primaryCompletion":52,"completion":408,"start":409,"enrollment":410,"conditions":411,"interventions":417},[],"2026-07-30","2024-10-20",600,[412,413,414,26,415,416],"ERAS","Gynecologic Cancer","Perioperative Complication","Quality of Life","Infections",[53,418],"Control group",{"intervention":418,"totalTrials":93,"cells":420},{"EARLY_PHASE1":421,"PHASE1":423,"PHASE2":425,"PHASE3":427,"PHASE4":429,"NA":431},{"trials":422,"activeCount":97},[],{"trials":424,"activeCount":97},[],{"trials":426,"activeCount":97},[],{"trials":428,"activeCount":97},[],{"trials":430,"activeCount":97},[],{"trials":432,"activeCount":93,"soonestReadout":52},[433],{"nctId":50,"briefTitle":51,"status":109,"phases":434,"primaryCompletion":52,"completion":408,"start":409,"enrollment":410,"conditions":435,"interventions":436},[],[412,413,414,26,415,416],[53,418],{"intervention":72,"totalTrials":93,"cells":438},{"EARLY_PHASE1":439,"PHASE1":441,"PHASE2":443,"PHASE3":445,"PHASE4":447,"NA":449},{"trials":440,"activeCount":97},[],{"trials":442,"activeCount":97},[],{"trials":444,"activeCount":97},[],{"trials":446,"activeCount":97},[],{"trials":448,"activeCount":97},[],{"trials":450,"activeCount":93,"soonestReadout":71},[451],{"nctId":69,"briefTitle":70,"status":132,"phases":452,"primaryCompletion":71,"completion":453,"start":454,"enrollment":455,"conditions":456,"interventions":461},[89],"2028-02","2026-05",200,[457,458,459,460],"Cuff Injury, Rotator","Arthroscopic Surgical Procedures","Stem Cell","PRP",[72,462],"Platelet-Rich Plasma (PRP) Injections",{"intervention":462,"totalTrials":93,"cells":464},{"EARLY_PHASE1":465,"PHASE1":467,"PHASE2":469,"PHASE3":471,"PHASE4":473,"NA":475},{"trials":466,"activeCount":97},[],{"trials":468,"activeCount":97},[],{"trials":470,"activeCount":97},[],{"trials":472,"activeCount":97},[],{"trials":474,"activeCount":97},[],{"trials":476,"activeCount":93,"soonestReadout":71},[477],{"nctId":69,"briefTitle":70,"status":132,"phases":478,"primaryCompletion":71,"completion":453,"start":454,"enrollment":455,"conditions":479,"interventions":480},[89],[457,458,459,460],[72,462],{"intervention":58,"totalTrials":93,"cells":482},{"EARLY_PHASE1":483,"PHASE1":485,"PHASE2":487,"PHASE3":489,"PHASE4":491,"NA":493},{"trials":484,"activeCount":97},[],{"trials":486,"activeCount":97},[],{"trials":488,"activeCount":97},[],{"trials":490,"activeCount":97},[],{"trials":492,"activeCount":97},[],{"trials":494,"activeCount":93,"soonestReadout":57},[495],{"nctId":55,"briefTitle":56,"status":262,"phases":496,"primaryCompletion":57,"completion":497,"start":498,"enrollment":499,"conditions":500,"interventions":504},[],"2027-03-30","2023-09-01",40,[501,502,503],"Chronic Rhinosinusitis With Nasal Polyps","Severe Eosinophilic Asthma","Chronic Rhinosinusitis Without Nasal Polyps",[58],{"intervention":77,"totalTrials":93,"cells":506},{"EARLY_PHASE1":507,"PHASE1":509,"PHASE2":511,"PHASE3":513,"PHASE4":515,"NA":517},{"trials":508,"activeCount":97},[],{"trials":510,"activeCount":97},[],{"trials":512,"activeCount":97},[],{"trials":514,"activeCount":97},[],{"trials":516,"activeCount":97},[],{"trials":518,"activeCount":93,"soonestReadout":76},[519],{"nctId":74,"briefTitle":75,"status":109,"phases":520,"primaryCompletion":76,"completion":521,"start":522,"enrollment":523,"conditions":524,"interventions":526},[89],"2027-12-15","2025-08-25",75,[525],"Periodontitis",[77],{"intervention":528,"totalTrials":93,"cells":529},"Liraglutide 6 MG\u002FML [Saxenda]",{"EARLY_PHASE1":530,"PHASE1":532,"PHASE2":534,"PHASE3":536,"PHASE4":538,"NA":553},{"trials":531,"activeCount":97},[],{"trials":533,"activeCount":97},[],{"trials":535,"activeCount":97},[],{"trials":537,"activeCount":97},[],{"trials":539,"activeCount":97},[540],{"nctId":541,"briefTitle":542,"status":543,"phases":544,"primaryCompletion":545,"completion":546,"start":547,"enrollment":499,"conditions":548,"interventions":551},"NCT04575194","Study of the Cardiometabolic Effects of Obesity Pharmacotherapy","UNKNOWN",[88],"2022-09-30","2023-05-30","2020-09-08",[549,550],"Obesity","Blood Pressure",[528,552],"Naltrexone-Bupropion Combination",{"trials":554,"activeCount":97},[],{"intervention":552,"totalTrials":93,"cells":556},{"EARLY_PHASE1":557,"PHASE1":559,"PHASE2":561,"PHASE3":563,"PHASE4":565,"NA":571},{"trials":558,"activeCount":97},[],{"trials":560,"activeCount":97},[],{"trials":562,"activeCount":97},[],{"trials":564,"activeCount":97},[],{"trials":566,"activeCount":97},[567],{"nctId":541,"briefTitle":542,"status":543,"phases":568,"primaryCompletion":545,"completion":546,"start":547,"enrollment":499,"conditions":569,"interventions":570},[88],[549,550],[528,552],{"trials":572,"activeCount":97},[],{"intervention":574,"totalTrials":93,"cells":575},"7-valent pneumococcal conjugate vaccine",{"EARLY_PHASE1":576,"PHASE1":578,"PHASE2":580,"PHASE3":582,"PHASE4":584,"NA":596},{"trials":577,"activeCount":97},[],{"trials":579,"activeCount":97},[],{"trials":581,"activeCount":97},[],{"trials":583,"activeCount":97},[],{"trials":585,"activeCount":97},[586],{"nctId":587,"briefTitle":588,"status":543,"phases":589,"primaryCompletion":590,"completion":591,"start":592,"enrollment":327,"conditions":593,"interventions":595},"NCT01346007","Study of 7-valent Pneumococcal Conjugate Vaccine in Children With Idiopathic Nephrotic Syndrome",[88],"2010-06","2011-06","2009-01",[594],"Idiopathic Nephrotic Syndrome",[574],{"trials":597,"activeCount":97},[],{"intervention":599,"totalTrials":93,"cells":600},"Carbetocin",{"EARLY_PHASE1":601,"PHASE1":603,"PHASE2":605,"PHASE3":607,"PHASE4":609,"NA":623},{"trials":602,"activeCount":97},[],{"trials":604,"activeCount":97},[],{"trials":606,"activeCount":97},[],{"trials":608,"activeCount":97},[],{"trials":610,"activeCount":97},[611],{"nctId":612,"briefTitle":613,"status":543,"phases":614,"primaryCompletion":615,"completion":616,"start":617,"enrollment":618,"conditions":619,"interventions":621},"NCT04300452","Carbetocin Versus Ergometrin in the Prevention of Postpartum Hemorrhage",[88],"2020-06-10","2020-09-30","2018-04-05",100,[620],"Postpartum Hemorrhage",[599,622],"Ergometrine Maleate",{"trials":624,"activeCount":97},[],{"intervention":622,"totalTrials":93,"cells":626},{"EARLY_PHASE1":627,"PHASE1":629,"PHASE2":631,"PHASE3":633,"PHASE4":635,"NA":641},{"trials":628,"activeCount":97},[],{"trials":630,"activeCount":97},[],{"trials":632,"activeCount":97},[],{"trials":634,"activeCount":97},[],{"trials":636,"activeCount":97},[637],{"nctId":612,"briefTitle":613,"status":543,"phases":638,"primaryCompletion":615,"completion":616,"start":617,"enrollment":618,"conditions":639,"interventions":640},[88],[620],[599,622],{"trials":642,"activeCount":97},[],{"intervention":644,"totalTrials":93,"cells":645},"Ferrous Gluconate 300 MG",{"EARLY_PHASE1":646,"PHASE1":648,"PHASE2":650,"PHASE3":652,"PHASE4":654,"NA":668},{"trials":647,"activeCount":97},[],{"trials":649,"activeCount":97},[],{"trials":651,"activeCount":97},[],{"trials":653,"activeCount":97},[],{"trials":655,"activeCount":97},[656],{"nctId":657,"briefTitle":658,"status":659,"phases":660,"primaryCompletion":661,"completion":661,"start":662,"enrollment":663,"conditions":664,"interventions":667},"NCT06049693","Iron Prehabilitation in Endometrial Cancer","COMPLETED",[88],"2024-01-01","2023-01-01",156,[665,414,666],"Endometrial Cancer","Prehabilitation",[644],{"trials":669,"activeCount":97},[],{"intervention":671,"totalTrials":93,"cells":672},"Heparin, Low-Molecular-Weight",{"EARLY_PHASE1":673,"PHASE1":675,"PHASE2":677,"PHASE3":679,"PHASE4":690,"NA":692},{"trials":674,"activeCount":97},[],{"trials":676,"activeCount":97},[],{"trials":678,"activeCount":97},[],{"trials":680,"activeCount":97},[681],{"nctId":682,"briefTitle":683,"status":659,"phases":684,"primaryCompletion":685,"completion":685,"start":686,"enrollment":327,"conditions":687,"interventions":688},"NCT01315093","Role of Heparin in Poor Responders Undergoing In Vitro Fertilisation",[86,87],"2016-06","2010-11",[15],[671,689],"no heparin",{"trials":691,"activeCount":97},[],{"trials":693,"activeCount":97},[],{"intervention":689,"totalTrials":93,"cells":695},{"EARLY_PHASE1":696,"PHASE1":698,"PHASE2":700,"PHASE3":702,"PHASE4":708,"NA":710},{"trials":697,"activeCount":97},[],{"trials":699,"activeCount":97},[],{"trials":701,"activeCount":97},[],{"trials":703,"activeCount":97},[704],{"nctId":682,"briefTitle":683,"status":659,"phases":705,"primaryCompletion":685,"completion":685,"start":686,"enrollment":327,"conditions":706,"interventions":707},[86,87],[15],[671,689],{"trials":709,"activeCount":97},[],{"trials":711,"activeCount":97},[],{"intervention":713,"totalTrials":93,"cells":714},"hCG",{"EARLY_PHASE1":715,"PHASE1":717,"PHASE2":719,"PHASE3":721,"PHASE4":734,"NA":736},{"trials":716,"activeCount":97},[],{"trials":718,"activeCount":97},[],{"trials":720,"activeCount":97},[],{"trials":722,"activeCount":97},[723],{"nctId":724,"briefTitle":725,"status":726,"phases":727,"primaryCompletion":728,"completion":728,"start":729,"enrollment":730,"conditions":731,"interventions":733},"NCT03423537","Low-dose HCG as an Adjunct to Ovarian Stimulation in Subfertile Women Undergoing ART","TERMINATED",[87],"2019-04-30","2018-06-01",80,[732],"HCG; IVF; Pregnancy Rates; ART; Chorionic Gonadotropin",[713],{"trials":735,"activeCount":97},[],{"trials":737,"activeCount":97},[],{"intervention":739,"totalTrials":93,"cells":740},"Platelet Rich Plasma Injections",{"EARLY_PHASE1":741,"PHASE1":743,"PHASE2":745,"PHASE3":747,"PHASE4":760,"NA":762},{"trials":742,"activeCount":97},[],{"trials":744,"activeCount":97},[],{"trials":746,"activeCount":97},[],{"trials":748,"activeCount":97},[749],{"nctId":750,"briefTitle":751,"status":543,"phases":752,"primaryCompletion":753,"completion":754,"start":755,"enrollment":327,"conditions":756,"interventions":759},"NCT05112718","Platelet Rich Plasma in Women With Urinary Incontinence",[86,87],"2022-05","2022-12","2021-07-01",[757,758],"Urinary Incontinence","Stress Urinary Incontinence",[739],{"trials":761,"activeCount":97},[],{"trials":763,"activeCount":97},[],{"intervention":765,"totalTrials":93,"cells":766},"Prednisolone and Heparin during COH for IVF",{"EARLY_PHASE1":767,"PHASE1":769,"PHASE2":771,"PHASE3":773,"PHASE4":785,"NA":787},{"trials":768,"activeCount":97},[],{"trials":770,"activeCount":97},[],{"trials":772,"activeCount":97},[],{"trials":774,"activeCount":97},[775],{"nctId":776,"briefTitle":777,"status":659,"phases":778,"primaryCompletion":779,"completion":779,"start":780,"enrollment":781,"conditions":782,"interventions":783},"NCT01590173","Addition of Prednisolone and Heparin in Patients Undergoing IVF With Failed IVF Cycles",[86,87],"2016-07","2012-01",86,[15],[765,784],"COH for IVF",{"trials":786,"activeCount":97},[],{"trials":788,"activeCount":97},[],{"intervention":784,"totalTrials":93,"cells":790},{"EARLY_PHASE1":791,"PHASE1":793,"PHASE2":795,"PHASE3":797,"PHASE4":803,"NA":805},{"trials":792,"activeCount":97},[],{"trials":794,"activeCount":97},[],{"trials":796,"activeCount":97},[],{"trials":798,"activeCount":97},[799],{"nctId":776,"briefTitle":777,"status":659,"phases":800,"primaryCompletion":779,"completion":779,"start":780,"enrollment":781,"conditions":801,"interventions":802},[86,87],[15],[765,784],{"trials":804,"activeCount":97},[],{"trials":806,"activeCount":97},[],{"intervention":808,"totalTrials":93,"cells":809},"Tranexamic Acid 15mg\u002Fkg , iv, Single Dose",{"EARLY_PHASE1":810,"PHASE1":812,"PHASE2":814,"PHASE3":828,"PHASE4":830,"NA":832},{"trials":811,"activeCount":97},[],{"trials":813,"activeCount":97},[],{"trials":815,"activeCount":97},[816],{"nctId":817,"briefTitle":818,"status":543,"phases":819,"primaryCompletion":820,"completion":821,"start":822,"enrollment":455,"conditions":823,"interventions":826},"NCT03251469","Single Dose of Tranexamic Acid and Blood Loss, in Elderly Patients With Hip Fracture",[86],"2017-12","2018-02","2013-01",[824,28,825],"Blood Loss, Surgical","Complication, Postoperative",[808,827],"Normal Saline, 100mg, iv, Singe dose",{"trials":829,"activeCount":97},[],{"trials":831,"activeCount":97},[],{"trials":833,"activeCount":97},[],{"intervention":827,"totalTrials":93,"cells":835},{"EARLY_PHASE1":836,"PHASE1":838,"PHASE2":840,"PHASE3":846,"PHASE4":848,"NA":850},{"trials":837,"activeCount":97},[],{"trials":839,"activeCount":97},[],{"trials":841,"activeCount":97},[842],{"nctId":817,"briefTitle":818,"status":543,"phases":843,"primaryCompletion":820,"completion":821,"start":822,"enrollment":455,"conditions":844,"interventions":845},[86],[824,28,825],[808,827],{"trials":847,"activeCount":97},[],{"trials":849,"activeCount":97},[],{"trials":851,"activeCount":97},[],{"intervention":853,"totalTrials":93,"cells":854},"Colchicine",{"EARLY_PHASE1":855,"PHASE1":857,"PHASE2":859,"PHASE3":872,"PHASE4":874,"NA":876},{"trials":856,"activeCount":97},[],{"trials":858,"activeCount":97},[],{"trials":860,"activeCount":97},[861],{"nctId":862,"briefTitle":863,"status":726,"phases":864,"primaryCompletion":865,"completion":865,"start":866,"enrollment":867,"conditions":868,"interventions":870},"NCT04326790","The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention",[86],"2020-04-27","2020-04-03",105,[869],"Corona Virus Disease 19 (Covid 19)",[853,871],"Standard treatment",{"trials":873,"activeCount":97},[],{"trials":875,"activeCount":97},[],{"trials":877,"activeCount":97},[],{"intervention":871,"totalTrials":93,"cells":879},{"EARLY_PHASE1":880,"PHASE1":882,"PHASE2":884,"PHASE3":890,"PHASE4":892,"NA":894},{"trials":881,"activeCount":97},[],{"trials":883,"activeCount":97},[],{"trials":885,"activeCount":97},[886],{"nctId":862,"briefTitle":863,"status":726,"phases":887,"primaryCompletion":865,"completion":865,"start":866,"enrollment":867,"conditions":888,"interventions":889},[86],[869],[853,871],{"trials":891,"activeCount":97},[],{"trials":893,"activeCount":97},[],{"trials":895,"activeCount":97},[],{"intervention":897,"totalTrials":93,"cells":898},"corifollitropin alfa",{"EARLY_PHASE1":899,"PHASE1":901,"PHASE2":903,"PHASE3":915,"PHASE4":917,"NA":919},{"trials":900,"activeCount":97},[],{"trials":902,"activeCount":97},[],{"trials":904,"activeCount":97},[905],{"nctId":906,"briefTitle":907,"status":659,"phases":908,"primaryCompletion":779,"completion":909,"start":910,"enrollment":911,"conditions":912,"interventions":913},"NCT01319695","Corifollitropin Alfa Versus Recombinant Follicle Stimulating Hormone (FSH) in Ovarian Stimulation of Women Undergoing in Vitro Fertilisation",[85,86],"2017-08","2011-01",140,[15],[897,914],"recombinant follicle stimulating hormone",{"trials":916,"activeCount":97},[],{"trials":918,"activeCount":97},[],{"trials":920,"activeCount":97},[],{"intervention":914,"totalTrials":93,"cells":922},{"EARLY_PHASE1":923,"PHASE1":925,"PHASE2":927,"PHASE3":933,"PHASE4":935,"NA":937},{"trials":924,"activeCount":97},[],{"trials":926,"activeCount":97},[],{"trials":928,"activeCount":97},[929],{"nctId":906,"briefTitle":907,"status":659,"phases":930,"primaryCompletion":779,"completion":909,"start":910,"enrollment":911,"conditions":931,"interventions":932},[85,86],[15],[897,914],{"trials":934,"activeCount":97},[],{"trials":936,"activeCount":97},[],{"trials":938,"activeCount":97},[],{"intervention":940,"totalTrials":93,"cells":941},"S26E",{"EARLY_PHASE1":942,"PHASE1":944,"PHASE2":946,"PHASE3":960,"PHASE4":962,"NA":964},{"trials":943,"activeCount":97},[],{"trials":945,"activeCount":97},[],{"trials":947,"activeCount":97},[948],{"nctId":949,"briefTitle":950,"status":726,"phases":951,"primaryCompletion":952,"completion":952,"start":953,"enrollment":16,"conditions":954,"interventions":959},"NCT04186377","Application of S26E for Diabetic Foot Ulcer Healing",[86],"2021-11-29","2020-05-15",[955,956,957,958],"Diabetic Foot","Neuropathic Foot Ulcer","Chronic Diabetic Ulcer of Left Foot (Diagnosis)","Chronic Diabetic Foot Ulcer of Right Foot",[940],{"trials":961,"activeCount":97},[],{"trials":963,"activeCount":97},[],{"trials":965,"activeCount":97},[],{"intervention":967,"totalTrials":93,"cells":968},"BNT162b2",{"EARLY_PHASE1":969,"PHASE1":971,"PHASE2":973,"PHASE3":975,"PHASE4":977,"NA":979},{"trials":970,"activeCount":97},[],{"trials":972,"activeCount":97},[],{"trials":974,"activeCount":97},[],{"trials":976,"activeCount":97},[],{"trials":978,"activeCount":97},[],{"trials":980,"activeCount":97},[981],{"nctId":982,"briefTitle":983,"status":543,"phases":984,"primaryCompletion":985,"completion":754,"start":986,"enrollment":410,"conditions":987,"interventions":993},"NCT04743388","Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System",[],"2022-08","2021-01-04",[988,989,990,991,992],"COVID-19","Healthy Volunteers","Chronic Disease","Hematological Malignancies","Solid Tumor",[967,994],"Other vaccine against SARS-Cov-2",{"intervention":994,"totalTrials":93,"cells":996},{"EARLY_PHASE1":997,"PHASE1":999,"PHASE2":1001,"PHASE3":1003,"PHASE4":1005,"NA":1007},{"trials":998,"activeCount":97},[],{"trials":1000,"activeCount":97},[],{"trials":1002,"activeCount":97},[],{"trials":1004,"activeCount":97},[],{"trials":1006,"activeCount":97},[],{"trials":1008,"activeCount":97},[1009],{"nctId":982,"briefTitle":983,"status":543,"phases":1010,"primaryCompletion":985,"completion":754,"start":986,"enrollment":410,"conditions":1011,"interventions":1012},[],[988,989,990,991,992],[967,994],{"intervention":1014,"totalTrials":93,"cells":1015},"DMARDs",{"EARLY_PHASE1":1016,"PHASE1":1018,"PHASE2":1020,"PHASE3":1022,"PHASE4":1024,"NA":1026},{"trials":1017,"activeCount":97},[],{"trials":1019,"activeCount":97},[],{"trials":1021,"activeCount":97},[],{"trials":1023,"activeCount":97},[],{"trials":1025,"activeCount":97},[],{"trials":1027,"activeCount":97},[1028],{"nctId":1029,"briefTitle":1030,"status":543,"phases":1031,"primaryCompletion":546,"completion":1032,"start":1033,"enrollment":327,"conditions":1034,"interventions":1036},"NCT05671627","Cortisol Circadian Rhythm in Patients With RA",[],"2023-06-30","2022-02-02",[1035],"Rheumatoid Arthritis",[1014],{"intervention":1038,"totalTrials":93,"cells":1039},"BCG",{"EARLY_PHASE1":1040,"PHASE1":1042,"PHASE2":1044,"PHASE3":1046,"PHASE4":1048,"NA":1050},{"trials":1041,"activeCount":97},[],{"trials":1043,"activeCount":97},[],{"trials":1045,"activeCount":97},[],{"trials":1047,"activeCount":97},[],{"trials":1049,"activeCount":97},[],{"trials":1051,"activeCount":97},[1052],{"nctId":1053,"briefTitle":1054,"status":659,"phases":1055,"primaryCompletion":1056,"completion":1056,"start":1057,"enrollment":618,"conditions":1058,"interventions":1060},"NCT05675176","Antegrade Observational Comparative Study for the Intravesical Instillation Therapy of Bacillus Calmette Guerin With the Use of Different Types of Urinary Catheters in Patients With Urinary Bladder Cancer",[],"2022-10-20","2020-04-12",[1059],"Non-muscle-invasive Bladder Cancer",[1038],{"intervention":1062,"totalTrials":93,"cells":1063},"Ropivacaine",{"EARLY_PHASE1":1064,"PHASE1":1066,"PHASE2":1068,"PHASE3":1070,"PHASE4":1072,"NA":1074},{"trials":1065,"activeCount":97},[],{"trials":1067,"activeCount":97},[],{"trials":1069,"activeCount":97},[],{"trials":1071,"activeCount":97},[],{"trials":1073,"activeCount":97},[],{"trials":1075,"activeCount":97},[1076],{"nctId":1077,"briefTitle":1078,"status":543,"phases":1079,"primaryCompletion":1080,"completion":1081,"start":1082,"enrollment":1083,"conditions":1084,"interventions":1087},"NCT05297422","Axillary Approach to Brachial Plexus Blockade Using Ketamine, Regional Versus Intravenous Administration",[89],"2023-05","2023-06","2022-01-20",81,[1085,1086],"Branchial Plexus Blockade","Anesthesia",[1062,1088],"Ketamine",{"intervention":1088,"totalTrials":93,"cells":1090},{"EARLY_PHASE1":1091,"PHASE1":1093,"PHASE2":1095,"PHASE3":1097,"PHASE4":1099,"NA":1101},{"trials":1092,"activeCount":97},[],{"trials":1094,"activeCount":97},[],{"trials":1096,"activeCount":97},[],{"trials":1098,"activeCount":97},[],{"trials":1100,"activeCount":97},[],{"trials":1102,"activeCount":97},[1103],{"nctId":1077,"briefTitle":1078,"status":543,"phases":1104,"primaryCompletion":1080,"completion":1081,"start":1082,"enrollment":1083,"conditions":1105,"interventions":1106},[89],[1085,1086],[1062,1088],{"intervention":1108,"totalTrials":93,"cells":1109},"Hormone Replacement cycle 1",{"EARLY_PHASE1":1110,"PHASE1":1112,"PHASE2":1114,"PHASE3":1116,"PHASE4":1118,"NA":1120},{"trials":1111,"activeCount":97},[],{"trials":1113,"activeCount":97},[],{"trials":1115,"activeCount":97},[],{"trials":1117,"activeCount":97},[],{"trials":1119,"activeCount":97},[],{"trials":1121,"activeCount":97},[1122],{"nctId":1123,"briefTitle":1124,"status":659,"phases":1125,"primaryCompletion":1126,"completion":1126,"start":1127,"enrollment":1128,"conditions":1129,"interventions":1131},"NCT03965949","Different Strategies in Frozen IVF\u002FICSI Cycles",[],"2019-12-02","2019-06-06",311,[1130],"Pregnancy Rates",[1108,1132],"Hormone Replacement cycle 2",{"intervention":1132,"totalTrials":93,"cells":1134},{"EARLY_PHASE1":1135,"PHASE1":1137,"PHASE2":1139,"PHASE3":1141,"PHASE4":1143,"NA":1145},{"trials":1136,"activeCount":97},[],{"trials":1138,"activeCount":97},[],{"trials":1140,"activeCount":97},[],{"trials":1142,"activeCount":97},[],{"trials":1144,"activeCount":97},[],{"trials":1146,"activeCount":97},[1147],{"nctId":1123,"briefTitle":1124,"status":659,"phases":1148,"primaryCompletion":1126,"completion":1126,"start":1127,"enrollment":1128,"conditions":1149,"interventions":1150},[],[1130],[1108,1132],{"intervention":1152,"totalTrials":93,"cells":1153},"Alcohol-based Chlorhexidine Gluconate 0.12%",{"EARLY_PHASE1":1154,"PHASE1":1156,"PHASE2":1158,"PHASE3":1160,"PHASE4":1162,"NA":1164},{"trials":1155,"activeCount":97},[],{"trials":1157,"activeCount":97},[],{"trials":1159,"activeCount":97},[],{"trials":1161,"activeCount":97},[],{"trials":1163,"activeCount":97},[],{"trials":1165,"activeCount":97},[1166],{"nctId":1167,"briefTitle":1168,"status":659,"phases":1169,"primaryCompletion":779,"completion":779,"start":1170,"enrollment":8,"conditions":1171,"interventions":1173},"NCT03119831","Effectiveness of Three Different Mouthrinses in Dental Plaque Control and Early Wound Healing",[89],"2015-11",[525,1172],"Wound Healing",[1152,1174,1175],"Alcohol-free Chlorhexidine Gluconate 0.12%","C31G",{"intervention":1174,"totalTrials":93,"cells":1177},{"EARLY_PHASE1":1178,"PHASE1":1180,"PHASE2":1182,"PHASE3":1184,"PHASE4":1186,"NA":1188},{"trials":1179,"activeCount":97},[],{"trials":1181,"activeCount":97},[],{"trials":1183,"activeCount":97},[],{"trials":1185,"activeCount":97},[],{"trials":1187,"activeCount":97},[],{"trials":1189,"activeCount":97},[1190],{"nctId":1167,"briefTitle":1168,"status":659,"phases":1191,"primaryCompletion":779,"completion":779,"start":1170,"enrollment":8,"conditions":1192,"interventions":1193},[89],[525,1172],[1152,1174,1175],{"intervention":1175,"totalTrials":93,"cells":1195},{"EARLY_PHASE1":1196,"PHASE1":1198,"PHASE2":1200,"PHASE3":1202,"PHASE4":1204,"NA":1206},{"trials":1197,"activeCount":97},[],{"trials":1199,"activeCount":97},[],{"trials":1201,"activeCount":97},[],{"trials":1203,"activeCount":97},[],{"trials":1205,"activeCount":97},[],{"trials":1207,"activeCount":97},[1208],{"nctId":1167,"briefTitle":1168,"status":659,"phases":1209,"primaryCompletion":779,"completion":779,"start":1170,"enrollment":8,"conditions":1210,"interventions":1211},[89],[525,1172],[1152,1174,1175],{"intervention":1213,"totalTrials":93,"cells":1214},"Propofol",{"EARLY_PHASE1":1215,"PHASE1":1217,"PHASE2":1219,"PHASE3":1221,"PHASE4":1223,"NA":1225},{"trials":1216,"activeCount":97},[],{"trials":1218,"activeCount":97},[],{"trials":1220,"activeCount":97},[],{"trials":1222,"activeCount":97},[],{"trials":1224,"activeCount":97},[],{"trials":1226,"activeCount":97},[1227],{"nctId":1228,"briefTitle":1229,"status":659,"phases":1230,"primaryCompletion":1231,"completion":1231,"start":1232,"enrollment":1233,"conditions":1234,"interventions":1235},"NCT04077827","TIVA Admnistration and Autologous Fat Transfer in Breast Reconstruction",[89],"2020-03-30","2019-09-01",46,[32],[1213],{"intervention":1237,"totalTrials":93,"cells":1238},"Empagliflozin",{"EARLY_PHASE1":1239,"PHASE1":1241,"PHASE2":1243,"PHASE3":1245,"PHASE4":1247,"NA":1249},{"trials":1240,"activeCount":97},[],{"trials":1242,"activeCount":97},[],{"trials":1244,"activeCount":97},[],{"trials":1246,"activeCount":97},[],{"trials":1248,"activeCount":97},[],{"trials":1250,"activeCount":97},[1251],{"nctId":1252,"briefTitle":1253,"status":659,"phases":1254,"primaryCompletion":1255,"completion":1255,"start":729,"enrollment":1256,"conditions":1257,"interventions":1260},"NCT05946148","Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18)",[],"2021-05-31",78,[1258,1259],"Non-Alcoholic Fatty Liver Disease","Liver Steatosis",[1237,1261,1262],"Dulaglutide","Control Rx",{"intervention":1261,"totalTrials":93,"cells":1264},{"EARLY_PHASE1":1265,"PHASE1":1267,"PHASE2":1269,"PHASE3":1271,"PHASE4":1273,"NA":1275},{"trials":1266,"activeCount":97},[],{"trials":1268,"activeCount":97},[],{"trials":1270,"activeCount":97},[],{"trials":1272,"activeCount":97},[],{"trials":1274,"activeCount":97},[],{"trials":1276,"activeCount":97},[1277],{"nctId":1252,"briefTitle":1253,"status":659,"phases":1278,"primaryCompletion":1255,"completion":1255,"start":729,"enrollment":1256,"conditions":1279,"interventions":1280},[],[1258,1259],[1237,1261,1262],{"intervention":1262,"totalTrials":93,"cells":1282},{"EARLY_PHASE1":1283,"PHASE1":1285,"PHASE2":1287,"PHASE3":1289,"PHASE4":1291,"NA":1293},{"trials":1284,"activeCount":97},[],{"trials":1286,"activeCount":97},[],{"trials":1288,"activeCount":97},[],{"trials":1290,"activeCount":97},[],{"trials":1292,"activeCount":97},[],{"trials":1294,"activeCount":97},[1295],{"nctId":1252,"briefTitle":1253,"status":659,"phases":1296,"primaryCompletion":1255,"completion":1255,"start":729,"enrollment":1256,"conditions":1297,"interventions":1298},[],[1258,1259],[1237,1261,1262],{"intervention":1300,"totalTrials":93,"cells":1301},"interleukin 17 inhibitor",{"EARLY_PHASE1":1302,"PHASE1":1304,"PHASE2":1306,"PHASE3":1308,"PHASE4":1310,"NA":1312},{"trials":1303,"activeCount":97},[],{"trials":1305,"activeCount":97},[],{"trials":1307,"activeCount":97},[],{"trials":1309,"activeCount":97},[],{"trials":1311,"activeCount":97},[],{"trials":1313,"activeCount":97},[1314],{"nctId":1315,"briefTitle":1316,"status":659,"phases":1317,"primaryCompletion":1318,"completion":1318,"start":1319,"enrollment":1320,"conditions":1321,"interventions":1325},"NCT07169682","Effects of IL17\u002F23 Inhibitors on Markers of Subclinical Atherosclerosis in Patients With Psoriasis",[],"2024-09-30","2021-09-01",66,[1322,1323,1324],"Psoriasis","Cardiovascular Disease","Atherosclerosis",[1300,1326,1327],"interleukin-23 inhibitor","conventional systemic agent or apremilast",{"intervention":1326,"totalTrials":93,"cells":1329},{"EARLY_PHASE1":1330,"PHASE1":1332,"PHASE2":1334,"PHASE3":1336,"PHASE4":1338,"NA":1340},{"trials":1331,"activeCount":97},[],{"trials":1333,"activeCount":97},[],{"trials":1335,"activeCount":97},[],{"trials":1337,"activeCount":97},[],{"trials":1339,"activeCount":97},[],{"trials":1341,"activeCount":97},[1342],{"nctId":1315,"briefTitle":1316,"status":659,"phases":1343,"primaryCompletion":1318,"completion":1318,"start":1319,"enrollment":1320,"conditions":1344,"interventions":1345},[],[1322,1323,1324],[1300,1326,1327],{"intervention":1327,"totalTrials":93,"cells":1347},{"EARLY_PHASE1":1348,"PHASE1":1350,"PHASE2":1352,"PHASE3":1354,"PHASE4":1356,"NA":1358},{"trials":1349,"activeCount":97},[],{"trials":1351,"activeCount":97},[],{"trials":1353,"activeCount":97},[],{"trials":1355,"activeCount":97},[],{"trials":1357,"activeCount":97},[],{"trials":1359,"activeCount":97},[1360],{"nctId":1315,"briefTitle":1316,"status":659,"phases":1361,"primaryCompletion":1318,"completion":1318,"start":1319,"enrollment":1320,"conditions":1362,"interventions":1363},[],[1322,1323,1324],[1300,1326,1327],{"intervention":1365,"totalTrials":93,"cells":1366},"Hydroxychloroquine",{"EARLY_PHASE1":1367,"PHASE1":1369,"PHASE2":1371,"PHASE3":1373,"PHASE4":1375,"NA":1377},{"trials":1368,"activeCount":97},[],{"trials":1370,"activeCount":97},[],{"trials":1372,"activeCount":97},[],{"trials":1374,"activeCount":97},[],{"trials":1376,"activeCount":97},[],{"trials":1378,"activeCount":97},[1379],{"nctId":1380,"briefTitle":1381,"status":659,"phases":1382,"primaryCompletion":1383,"completion":1384,"start":1385,"enrollment":327,"conditions":1386,"interventions":1388},"NCT04153201","Hydroxychloroquine for Thrombosis Prevention and Antiphospholipid Antibody Reduction in Primary Antiphospholipid Syndrome",[89],"2019-10-01","2019-10-16","2013-01-15",[1387],"Antiphospholipid Syndrome",[1365]]